Zometa (Zoledronic acid for injection) Novartis

News
Article

NMEs/biologics:Short-infusion bisphosphonate for hypercalcemia of malignancy

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Presbyopia Treatment, VIZZ

FDA Approves Presbyopia Treatment, VIZZ

Logan Lutton
August 7th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 7th 2025
Podcast

Listen

Creative mind-stock@adobe.com

PBM-Offered Genomics Testing Could Reshape Prescribing of Medications

Denise Myshko
August 7th 2025
Article

Read More

Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults

Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults

Briana Contreras
August 7th 2025
Article

Read More

nikitos77-stock@adobe.com

PBM Reform Could Save Almost $100 Billion in U.S. Drug Spending

Denise Myshko
August 7th 2025
Article

Read More

luchschenF-stock@adobe.com

FDA Extends Review of Blenrep Combinations in Multiple Myeloma

Denise Myshko
August 7th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.